Delayed, post-injury treatment with aniracetam improves cognitive performance after traumatic brain injury in rats

Journal of Neurotrauma

Volumn 23, Issue 8, 2006, Pages 1233-1240

  Baranova, Anna I ^a   Whiting, Mark D ^a   Hamm, Robert J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Aniracetam; Brain injury; Cognitive recovery; Morris water maze; Rat; Traumatic brain injury

Indexed keywords

ANIRACETAM; NEUROTRANSMITTER; NOOTROPIC AGENT; 2 PYRROLIDONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CONVALESCENCE; DOSE RESPONSE; DRUG EFFICACY; DRUG INDICATION; LATENT PERIOD; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; OPTIMAL DRUG DOSE; RAT; THERAPY DELAY; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; ANIMAL; BRAIN INJURY; DRUG EFFECT; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BRAIN INJURIES; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MAZE LEARNING; NOOTROPIC AGENTS; PSYCHOMOTOR PERFORMANCE; PYRROLIDINONES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 33750121629     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2006.23.1233     Document Type: Article

References (41)

1. BOYESON, M.G., and FEENEY, D.M. (1990). Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol. Biochem. Behav. 35, 497-501.
2. BOYESON, M.G., and HARMON, R.L. (1993). Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am. J. Phys. Med. Rehabil. 72, 286-293.
3. BULLOCK, R., LYETH, B.G., and MUIZELAAR, J.P. (1999). Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies. Neurosurgery 45, 217-220.
4. DIXON, C.E., LYETH, B.G., POVLISHOCK, J.T., et al. (1987). A fluid percussion model of experimental traumatic brain injury in the rat. J. Neurosurg. 67, 110-119.
5. 3H]-choline uptake but not extracellular choline levels in rats. Neurosci. Lett. 180, 127-130.
6. DIXON, C.E., HAMM, R.J., TAFT, W.C., and HAYES, R.L. (1994). Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. J. Neurotrauma 11, 275-287.
7. DIXON, C.E., BAO, J., LONG, D.A., and HAYES, R.L. (1996). Reduced evoked release of acetylcholine in the rodent hippocampus following traumatic brain injury. Pharm. Biochem. Behav. 53, 679-686.
8. DIXON, C.E., MA, X., and MARION, D.W. (1997). Effects of CDP-Choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release. J. Neurotrauma 14, 159-166.
9. DIXON, C.E., KRAUS, M.F., KLINE, et al. (1999). Amantadine improves water maze performance without affecting motor behavior following traumatic brain injury in rats. Restor. Neurol. Neurosci. 14, 285-294.
10. DUNN-MEYNELL, A., PAN, S., and LEVIN, B.E. (1994). Focal traumatic brain injury causes widespread reductions in rat brain norepinephrine turnover from 6 to 24 h. Brain Res. 660, 88-95.
11. FEENEY, D.M. (1991). Pharmacologic modulation of recovery after brain injury: a reconsideration of diaschisis. J. Neurol. Rehabil. 5, 113-128.
12. FEENEY, D.M., and SUTTON, R.L. (1987). Pharmacotherapy for recovery of function after brain injury. Crit. Rev. Neurobiol. 3, 135-197.
13. FEENEY, D.M., WEISEND, M.P., and KLINE, A.E. (1993). Noradrenergic pharmacotherapy, intracerebral infusion and adrenal transplantation promote functional recovery after cortical damage. J. Neural Transplant. Plast. 4, 199-213.
14. FEENEY, D.M. (1997). From laboratory to clinic: noradrenergic enhancement of physical therapy for stroke or trauma patients. Adv. Neurol. 73, 383-394.
15. FUSHIKI, S., MATSUMOTO, K., and NAGATA, A. (1995). Neurite outgrowth of murine cerebellar granule cells can be enhanced by aniracetam with or without alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA). Neurosci. Lett. 199, 171-174.
16. HUGER, F, and PATRICK, G. (1979). Effect of concussive head injury on central catecholamine levels and synthesis rates in rat brain regions. J. Neurochem. 33, 89-95.
17. JOLKKONEN, J., PUURUNEN, K., RANTAKOMI, S., HARKONEN, A., HAAPALINNA, A., and SIVENIUS, J. (2000). Behavioral effects of the alpha2-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats. Eur. J. Pharmacol. 400, 211-219.
18. KIKUCHI, K., NISHINO, K., and OHYU, H. (2000). Increasing CNS norepinephrine levels by the precursor L-DOPS facilitates beam-walking recovery after sensorimotor cortex ablation in rats. Brain Res. 860, 130-135.
19. KLINE, A.E., MASSUCCI, J.L., MARION, D.W., and DIXON, C.E. (2002). Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J. Neurotrauma 19, 415-425.
20. LEVIN, B.E., BROWN, K.L., PAWAR, G., and DUNN-MEYNELL, A. (1995). Widespread and lateralization effects of acute traumatic brain injury on norepinephrine turnover in the rat brain. Brain Res. 674, 307-313.
21. LEBRUM, C., PILLIERE, E., and LESTAGE, P. (2000). Effects of S18986-1, a novel cognitive enhancer, on memory performance in an object recognition task in rats. Eur. J. Pharmacol. 401, 205-212.
22. LEONARD, J.R., MARIS, D.O., and GRADY, M.S. (1994). Fluid percussion injury causes loss of forebrain choline acetyltransferase and nerve growth factor receptor immunoreactive cells in the rat. J. Neurotrauma 11, 379-392.
23. LU, Y., and WEHNER, J.M. (1997). Enhancement of contextual fear-conditioning by putative AMPA receptor modulators and NMDA receptor antagonists in DBA/2J mice. Brain Res. 68, 197-207.
24. LYETH, B.G., JENKINS, L.W., HAMM, R.J., et al. (1990). Prolonged memory impairment in the absence of cell death following traumatic brain injury in the rat. Brain Res. 526, 249-258.
25. MAAS, A.I. (2001). Neuroprotective agents in traumatic brain injury. Expert Opin. Invest. Drugs 10, 753-767.
26. MCINTOSH, T.K., YU, T., and GENNARELLI, T.A. (1994). Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J. Neurochem. 63, 1426-1433.
27. MCINTOSH, T.K., JUHLER, M., and WIELOCH, T. (1998). Novel pharmacological strategies in the treatment of experimental traumatic brain injury. J. Neurotrauma 15, 731-770.
28. NAKAMURA, K., and SHIRANE, M. (1999). Activation of the reticulothalamic cholinergic pathway by the major metabolites of aniracetam. Eur. J. Pharmacol. 380, 81-89.
29. A receptor, attenuates cognitive impairment in rats following traumatic brain injury. J. Neurosurg. 83, 878-883.
30. OUCHI, Y., KAKIUCHI, T., OKADA, H., NISHIYAMA, S., and TSUKADA, H. (1999). The effect of aniracetam on cerebral glucose metabolism in rats after lesioning of the basal forebrain measured by PET. J. Neurol. Sci. 164, 7-12.
31. PIKE, B.R., and HAMM, R.J. (1995). Post-injury administration of BIBN 99, a selective muscarinic M2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats. Brain Res. 686, 37-43.
32. PIKE, B.R., and HAMM, R.J. (1997a). Chronic administration of a partial muscarinic M1 receptor agonist attenuates decreases in forebrain choline acetyltransferase immunoreactivity folowing experimental brain trauma. Exp. Neurol. 147, 55-65.
33. PIKE, B.R., and HAMM, R.J. (1997b). Activating the post-traumatic cholinergic system for the treatment of cognitive impairment following traumatic brain injury. Pharm. Biochem. Behav. 57, 785-791.
34. PIZZI, M., FALLACARA, C., ARRIGHI, V., MEMO, M., and SPANO, P.E. (1993). Attenuation of excitatory amino acid toxicity by metabotropic receptor agonists and aniracetam in primary cultures of cerebellular granule cells. J. Neurochem. 61, 683-689.
35. SATOH, M., ISHIHARA, K., IWAMA, T., and TAKAGI, H. (1986). Aniracetam augments, and midazolam inhibits, the long-term potentiation in guinea-pig hippocampal slices. Neurosci. Lett. 68, 216-220.
36. TOGASHI, H., KIMURA, S., MATSUMOTO, M., YOSHIOKA, M., MINAMI, M., and SAITO, H. (1996). Cholinergic changes in the hippocampus of stroke-prone spontaneously hypertensive rats. Stroke 27, 520-525.
37. TOGASHI, H., NAKAMURA, K., MATSUMOTO, M., et al. (2002). Aniracetam enhances glutamatergic transmission in the prefrontal cortex of stroke-prone spontaneously hypertensive rats. Neurosci. Lett. 320, 109-112.
38. VON MONAKOW, C. (1969). Diaschisis, the localization in the cerebrum and functional impairment by cortical loci, in Brain and Behavior: Moods, States, and Mind. K. Pribram (ed), Penguin Books: Baltimore, pps. 27-36.
39. YOSHINO, A., HOVDA, D.A., KAWAMATA, T., KATAYAMA, Y., and BECKER, D.P. (1991). Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of hyper- and subsequent hypometabolic state. Brain Res. 561, 106-119.
40. ZAJACZKOWSKI, W., and DANYSZ, W. (1997). Effects of D-cycloserine and aniracetam on spatial learning in rats with entorhinal cortex lesions. Pharmacol. Biochem. Behav. 56, 21-29.
41. ZHU, J., HAMM, R.J., REEVES, T.M., POVLISHOCK, J.T., and PHILLIPS, L.L. (2000). Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp. Neurol. 166, 136-152.